These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38009844)

  • 1. The Cost-Effectiveness of Early High-Acuity Postoperative Care for Medium-Risk Surgical Patients.
    Leaman EE; Ludbrook GL
    Anesth Analg; 2024 Aug; 139(2):323-331. PubMed ID: 38009844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Effectiveness in Perioperative Care: Application of Markov Modeling to Pathways of Perioperative Care.
    Ludbrook GL; Leaman E
    Value Health; 2022 Feb; 25(2):215-221. PubMed ID: 35094794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Postoperative Overnight High-Acuity Care in Medium-Risk Patients Undergoing Elective and Unplanned Noncardiac Surgery.
    Ludbrook G; Grocott MPW; Heyman K; Clarke-Errey S; Royse C; Sleigh J; Solomon LB
    JAMA Surg; 2023 Jul; 158(7):701-708. PubMed ID: 37133876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dedicated Perioperative Hip Fracture Comanagement Programs are Cost-effective in High-volume Centers: An Economic Analysis.
    Swart E; Vasudeva E; Makhni EC; Macaulay W; Bozic KJ
    Clin Orthop Relat Res; 2016 Jan; 474(1):222-33. PubMed ID: 26260393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk.
    Fairbairn TA; Meads DM; Hulme C; Mather AN; Plein S; Blackman DJ; Greenwood JP
    Heart; 2013 Jul; 99(13):914-20. PubMed ID: 23696198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.
    Shepherd J; Jones J; Frampton GK; Tanajewski L; Turner D; Price A
    Health Technol Assess; 2008 Jun; 12(28):iii-iv, ix-95. PubMed ID: 18547499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost effectiveness of REACH-HF and home-based cardiac rehabilitation compared with the usual medical care for heart failure with reduced ejection fraction: A decision model-based analysis.
    Taylor RS; Sadler S; Dalal HM; Warren FC; Jolly K; Davis RC; Doherty P; Miles J; Greaves C; Wingham J; Hillsdon M; Abraham C; Frost J; Singh S; Hayward C; Eyre V; Paul K; Lang CC; Smith K
    Eur J Prev Cardiol; 2019 Aug; 26(12):1252-1261. PubMed ID: 30884975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?
    Albright RH; Joseph RM; Wukich DK; Armstrong DG; Fleischer AE
    Clin Orthop Relat Res; 2020 Dec; 478(12):2869-2888. PubMed ID: 32694315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer.
    Sherman SK; Lange JJ; Dahdaleh FS; Rajeev R; Gamblin TC; Polite BN; Turaga KK
    JAMA Oncol; 2019 Feb; 5(2):236-242. PubMed ID: 30489611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost-utility and cost-effectiveness analysis of an acute pain service.
    Stadler M; Schlander M; Braeckman M; Nguyen T; Boogaerts JG
    J Clin Anesth; 2004 May; 16(3):159-67. PubMed ID: 15217653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of the RefluxStop device for management of refractory gastroesophageal reflux disease in Switzerland.
    Harper S; Kartha M; Mealing S; Borbély YM; Zehetner J
    J Med Econ; 2024; 27(1):805-815. PubMed ID: 38820006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical and economic evaluation of fast-track recovery after cardiac surgery.
    Salhiyyah K; Elsobky S; Raja S; Attia R; Brazier J; Cooper GJ
    Heart Surg Forum; 2011 Dec; 14(6):E330-4. PubMed ID: 22167756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation.
    Pandor A; Thokala P; Gomersall T; Baalbaki H; Stevens JW; Wang J; Wong R; Brennan A; Fitzgerald P
    Health Technol Assess; 2013 Aug; 17(32):1-207, v-vi. PubMed ID: 23927840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of endovascular repair, open repair, and conservative management of splenic artery aneurysms.
    Hogendoorn W; Lavida A; Hunink MG; Moll FL; Geroulakos G; Muhs BE; Sumpio BE
    J Vasc Surg; 2015 Jun; 61(6):1432-40. PubMed ID: 25827968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective.
    Takeshima T; Sakai F; Wang X; Yamato K; Kojima Y; Zhang Y; Bennison C; Simons MJHG
    Pharmacoeconomics; 2024 Jul; 42(7):811-822. PubMed ID: 38771521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the Cost-Effectiveness of the ABCDE Bundle: Impact of Bundle Adherence on Inpatient and 1-Year Mortality and Costs of Care.
    Collinsworth AW; Priest EL; Masica AL
    Crit Care Med; 2020 Dec; 48(12):1752-1759. PubMed ID: 33003078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of a breast cancer care programme including ultra short hospital stay in 4 early adopter centres: framework for an implementation study.
    de Kok M; Frotscher CN; van der Weijden T; Kessels AG; Dirksen CD; van de Velde CJ; Roukema JA; Bell AV; van der Ent FW; von Meyenfeldt MF
    BMC Cancer; 2007 Jul; 7():117. PubMed ID: 17605796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model Approach.
    Koenig L; Zhang Q; Austin MS; Demiralp B; Fehring TK; Feng C; Mather RC; Nguyen JT; Saavoss A; Springer BD; Yates AJ
    Clin Orthop Relat Res; 2016 Dec; 474(12):2645-2654. PubMed ID: 27699631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat® fixed-dose combination for chronic obstructive pulmonary disease patients in Italy.
    Selya-Hammer C; Gonzalez-Rojas Guix N; Baldwin M; Ternouth A; Miravitlles M; Rutten-van Mölken M; Goosens LM; Buyukkaramikli N; Acciai V
    Ther Adv Respir Dis; 2016 Oct; 10(5):391-401. PubMed ID: 27405723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.